HAS
33
3
CSCO
67
4
VMC
57
4
ILMN
42
5
WDC
47
4
FDX
43
3
SE
61
-4
PBI
69
4
WBA
48
4
KLAC
47
4
HBI
59
4
WU
32
2
NWL
53
3
CFG
70
6
HP
48
3
PAYX
53
2
GPC
40
3
KEY
46
3
ADSK
70
2
COF
60
2
HAS
33
3
CSCO
67
4
VMC
57
4
ILMN
42
5
WDC
47
4
FDX
43
3
SE
61
-4
PBI
69
4
WBA
48
4
KLAC
47
4
HBI
59
4
WU
32
2
NWL
53
3
CFG
70
6
HP
48
3
PAYX
53
2
GPC
40
3
KEY
46
3
ADSK
70
2
COF
60
2
Financhill
Back

Bicycle Therapeutics PLC Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23

BCYC
Bicycle Therapeutics PLC

Last Price:
20.57
Seasonality Move:
25.62%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Bicycle Therapeutics PLC Price Quote

$20.57
+0.03 (+1.53%)
(Updated: November 23, 2024 at 5:26 AM ET)

Bicycle Therapeutics PLC Key Stats

Sell
23
Bicycle Therapeutics PLC (BCYC) is a Sell
Day range:
$20.26 - $21.60
52-week range:
$13.31 - $28.67
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
28.67
P/B ratio:
1.71%
Volume:
284.4K
Avg. volume:
460.7K
1-year change:
48.63%
Market cap:
$1.4B
Revenue:
$27M
EPS:
$-3.29

How Much Does Bicycle Therapeutics PLC Make?

Is Bicycle Therapeutics PLC Growing As A Company?

Bicycle Therapeutics PLC Stock Price Performance

What Is Bicycle Therapeutics PLC 52-Week High & Low?

Bicycle Therapeutics PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Bicycle Therapeutics PLC?

Is Bicycle Therapeutics PLC Cash Flow Positive?

  • What Is BCYC Cash Flow From Operations?
    Cash flow from operations (TTM) is -$202.6M
  • What Is Bicycle Therapeutics PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $519.9M
  • What Is Bicycle Therapeutics PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$918K

Bicycle Therapeutics PLC Return On Invested Capital

  • Is Management Doing A Good Job?
    BCYC return on invested capital is -27.99%
  • What Is Bicycle Therapeutics PLC Return On Assets?
    ROA measures how assets are converting to revenues and is -21.68%
  • What Is BCYC Return On Equity?
    ROE is a measure of profitability and is -29.19%

Bicycle Therapeutics PLC Earnings Date & Stock Price

Bicycle Therapeutics PLC Competitors

Bicycle Therapeutics PLC Dividend Yield

Bicycle Therapeutics PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 7.46%
Revenue: -50% -61.8%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 37.82
Upside from Last Price: 84.12%

Major Shareholders

  • How many BCYC shares are owned by institutional investors?
    55M BCYC shares are owned by institutional investors
  • How many BCYC shares are owned by insiders?
    1.1M BCYC shares are owned by insiders